FSPHX
Price
$24.56
Change
-$0.19 (-0.77%)
Updated
May 22 closing price
Net Assets
6.2B
HGHIX
Price
$35.00
Change
-$0.29 (-0.82%)
Updated
May 22 closing price
Net Assets
794.37M
Interact to see
Advertisement

FSPHX vs HGHIX

Header iconFSPHX vs HGHIX Comparison
Open Charts FSPHX vs HGHIXBanner chart's image
Fidelity Select Health Care
Price$24.56
Change-$0.19 (-0.77%)
VolumeN/A
Net Assets6.2B
Hartford Healthcare I
Price$35.00
Change-$0.29 (-0.82%)
VolumeN/A
Net Assets794.37M
FSPHX vs HGHIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSPHX vs. HGHIX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPHX is a Buy and HGHIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.2B vs. HGHIX (794M). HGHIX pays higher dividends than FSPHX: HGHIX (0.43) vs FSPHX (0.02). FSPHX was incepted earlier than HGHIX: FSPHX (44 years) vs HGHIX (19 years). HGHIX (1.02) is less costly to investors than FSPHX (0.63). FSPHX (40.00) and HGHIX (40.00) have comparable annual turnover. FSPHX has a lower initial minimum investment than HGHIX: FSPHX (0) vs HGHIX (2000). FSPHX annual gain was more profitable for investors over the last year : -14.20 vs. HGHIX (-17.15). HGHIX return over 5 years is better than : -13.78 vs. FSPHX (-14.75).
FSPHXHGHIXFSPHX / HGHIX
Total Expense Ratio0.631.0262%
Annual Report Gross Expense Ratio0.631.0262%
Fund Existence44 years19 years-
Gain YTD-9.174-7.472123%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.2B794M781%
Annual Yield % from dividends0.020.434%
Returns for 1 year-14.20-17.1583%
Returns for 3 years-2.27-4.4451%
Returns for 5 years-14.75-13.78107%
Returns for 10 years3.75-15.29-25%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QILGX37.04N/A
N/A
Federated Hermes MDT Large Cap Growth IS
MWOKX64.30N/A
N/A
MFS Global Growth R6
TRZDX79.71N/A
N/A
T. Rowe Price Dividend Growth Z
FMKFX19.76N/A
N/A
Fidelity Magellan K6
BMPEX24.95-0.06
-0.24%
Beck Mack + Oliver Partners